Anaplasia refers to:

Explanation

## Correct Answer: A. Lack of differentiation Anaplasia is the hallmark of **loss of differentiation** in malignant tumors. The term derives from Greek "ana" (backward) + "plassein" (to form), literally meaning "to form backward" — a reversion to a primitive, undifferentiated state. In anaplastic tumors, cells lose their specialized morphologic and functional features and revert toward the phenotype of their tissue of origin's precursor cells. This is the defining pathologic criterion of anaplasia. Anaplastic tumors typically show high mitotic rates, tumor necrosis, and aggressive biologic behavior. Histologically, they lack the organized architecture and cytodifferentiation seen in well-differentiated tumors. Classic examples in Indian practice include anaplastic thyroid carcinoma (most aggressive thyroid malignancy), anaplastic large-cell lymphoma, and high-grade sarcomas. The Broders grading system (Grade I–IV) uses degree of differentiation as the primary parameter; Grade IV tumors are anaplastic. Loss of differentiation is the core definition — the other options describe secondary morphologic features that may accompany anaplasia but are not its definition. ## Why the other options are wrong **B. Variation in cell size and shape** — This describes **pleomorphism** (cellular heterogeneity), a common feature of malignant tumors but not the defining criterion of anaplasia. Pleomorphism is a secondary consequence of loss of differentiation and chromosomal instability, not anaplasia itself. Well-differentiated tumors can show some pleomorphism; conversely, anaplastic tumors are defined by loss of differentiation, not merely by size/shape variation. **C. Disordered arrangement of tumor cells** — This describes **loss of architectural organization** or **loss of cohesion**, which reflects dedifferentiation but is not the definition of anaplasia. Disorganized growth pattern is a consequence of loss of cell-cell adhesion and differentiation, not the primary definition. Anaplasia is specifically about loss of cellular differentiation, not tissue architecture. **D. Replacement of one type of cell by other** — This describes **metaplasia** (reversible replacement of one differentiated cell type by another) or **transdifferentiation**, which is fundamentally different from anaplasia. Metaplasia is a reversible adaptive response to chronic irritation (e.g., Barrett's esophagus, intestinal metaplasia in gastric mucosa); anaplasia is irreversible loss of differentiation in malignant cells. These are opposite processes. ## High-Yield Facts - **Anaplasia** = loss of differentiation (reversion to primitive phenotype), the core definition in Broders grading - **Broders Grade IV** tumors are anaplastic; Grade I are well-differentiated; differentiation is the primary grading parameter - **Anaplastic thyroid carcinoma** is the most aggressive thyroid malignancy in India; 5-year survival <10% due to high anaplasia - **Pleomorphism, high mitotic rate, tumor necrosis** are secondary features accompanying anaplasia, not its definition - **Metaplasia** (reversible cell-type replacement) is distinct from anaplasia (irreversible loss of differentiation in malignancy) ## Mnemonics **ANAPLASIA vs METAPLASIA** **A**naplasia = **A**bnormal (malignant, irreversible, loss of differentiation); **M**etaplasia = **M**odifiable (benign, reversible, cell-type swap). Use when distinguishing neoplastic from non-neoplastic changes. **Broders Grading (I–IV)** Grade I = Well-differentiated (best prognosis); Grade IV = Anaplastic (worst prognosis). Differentiation is the key — higher grade = lower differentiation = higher anaplasia. ## NBE Trap NBE pairs anaplasia with pleomorphism and disorganized growth to lure students into confusing secondary morphologic features with the primary definition. The trap is that all three wrong options describe real features of malignant tumors, but only lack of differentiation is the defining criterion of anaplasia. ## Clinical Pearl In Indian cancer registries, anaplastic thyroid carcinoma represents ~5% of thyroid cancers but accounts for disproportionate mortality due to complete loss of differentiation and rapid progression. Recognizing anaplasia on histology immediately signals aggressive behavior and guides treatment intensity — a critical bedside correlation for oncology practice. _Reference: Robbins and Cotran Pathologic Basis of Disease, Ch. 6 (Neoplasia); Park's Textbook of Preventive and Social Medicine, Ch. on Cancer Epidemiology_